Haiko J Bloemendal

5PUBLICATIONS
29CO-AUTHORS
PharmacogenomicsMolecular targetsCancer geneticsAccounting theory and standards
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparib.

Joanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer

|Jul 01, 2024
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients.

Marise R Heerma van Voss, Jessica Notohardjo, Joyce van Dodewaard-de Jong

|Jun 27, 2024
Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery Protocol.

Jade M van Berge Henegouwen, Laurien J Zeverijn, Birgit S Geurts

|Feb 13, 2023
A Systematic Review and Multilevel Regression Analysis Reveals the Comorbidity Prevalence in Cancer.

Cilla E J Vrinzen, Linn Delfgou, Niek Stadhouders

|Nov 08, 2021
Manufacturers' views on outcome-based agreements.

Sahar Barjestehvan Waalwijk van Doorn-Khosrovani, Lonneke Timmers, Anke Pisters-van Roy

Pageof 1